Aktis lands biotech's first IPO of 2026, raising $318M for radiopharmaceuticals
Aktis lands biotech's first IPO of 2026, raising $318M for radiopharmaceuticals
Aktis lands biotech's first IPO of 2026, raising $318M for radiopharmaceuticals
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page